What classification does Bictegravir belong to?

Bictegravir is classified as an Integrase Inhibitor, which is a type of antiretroviral medication used in the treatment of HIV. This classification refers to its mechanism of action, where it interferes with the integrase enzyme that HIV uses to integrate its genetic material into the host cell’s DNA. By inhibiting this specific enzyme, bictegravir effectively reduces the ability of the virus to replicate within the body.

Integrase Inhibitors are a key component of modern HIV treatment regimens, as they are known for their effectiveness and relatively favorable side effect profile. Bictegravir, often used in combination with other antiretroviral drugs, helps achieve and maintain viral suppression in individuals living with HIV.

Understanding the role of different classifications of antiretroviral drugs, including integrase inhibitors, is crucial for recognizing how they function in the management of HIV and the rationale behind their use in therapy.